Detalhe da pesquisa
1.
[Myositis-specific antibodies associated with juvenile dermatomyositis]. / Myositisspezifische Antikörper bei juveniler Dermatomyositis.
Z Rheumatol
; 77(8): 735-740, 2018 Oct.
Artigo
Alemão
| MEDLINE | ID: mdl-29411095
2.
Infliximab is an appropriate second-line therapy in infants with steroid refractory pyoderma gangrenosum.
J Eur Acad Dermatol Venereol
; 36(5): e376-e378, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35037304
3.
[Connective tissue diseases in adolescents]. / Kollagenosen bei Jugendlichen.
Hautarzt
; 67(4): 271-8, 2016 Apr.
Artigo
Alemão
| MEDLINE | ID: mdl-27000182
4.
Musculoskeletal pain: a new algorithm for differential diagnosis of a cardinal symptom in pediatrics.
Klin Padiatr
; 226(2): 86-98, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24687611
5.
Canakinumab for first line steroid-free treatment in a child with systemic-onset juvenile idiopathic arthritis.
Scand J Rheumatol
; 46(6): 500-501, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28266235